Literature DB >> 28182787

It's more than dryness and fatigue: The patient perspective on health-related quality of life in Primary Sjögren's Syndrome - A qualitative study.

Angelika Lackner1, Anja Ficjan1, Martin H Stradner1, Josef Hermann1, Julia Unger2, Tanja Stamm3, Georg Stummvoll3, Mona Dür4,5, Winfried B Graninger1, Christian Dejaco1,6.   

Abstract

OBJECTIVES: In Primary Sjögren's Syndrome (PSS), there is an apparent lack of data concerning the perspectives of patients, their needs, preferences and difficulties of daily life. This qualitative study was conducted to explore perspectives and needs of patients with PSS that influence health related quality of life (HRQL).
METHODS: We recruited 20 PSS patients fulfilling the American-European consensus classification criteria out of the PSS cohort of the Medical University Graz, Austria. In total, 6 focus group sessions (with three to four patients per group) were performed. A modified meaning condensation procedure was used to analyse the data.
RESULTS: The interview analysis resulted in 484 meaning units, 254 subconcepts and 86 concepts. The identified concepts were grouped into three dimensions: physical dimension, psychological & emotional challenges and social life & daily living. A dependency between the three categories was identified. The concepts most commonly reported by patients were related to the physical dimension: pain and dryness as well as complaints associated with/provoked by these symptoms. Patients also reported shortness of breath, fatigue und constipation.
CONCLUSIONS: This qualitative study underpins that HRQL in PSS patients is affected by several factors. The problems are not limited to dryness, pain and fatigue while the complaints secondary to these symptoms are important to patients with PSS significantly affecting physical, psychological and social life components of HRQL. A disease-specific patient related outcome measures for clinical practice and trials should be developed considering the different aspects of HRQL in PSS.

Entities:  

Mesh:

Year:  2017        PMID: 28182787      PMCID: PMC5300216          DOI: 10.1371/journal.pone.0172056

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Primary Sjögren’s Syndrome (PSS) is one of the most common systemic autoimmune disorders affecting 0.3–5% of the general population [1-4]. PSS predominantly occurs in women (female: male ratio 9:1) and its incidence peaks in the fifth and sixth decade of life [5,6]. Inflammation of lacrimal and salivary glands results in decreased production of tears and saliva causing dryness of eyes, mouth, gastrointestinal and genital tract as well as skin. A high proportion of patients also experience extraglandular manifestations including fatigue, musculoskeletal, gastrointestinal and/or neurological symptoms [7]. Furthermore, PSS patients are at a higher risk of developing malignancies, particularly non-Hodgkin’s Lymphomaod [8-12]. Therapy of PSS is often symptomatic focusing on the management of sicca symptoms, pain and fatigue [13,14]. Previous studies reported that health related quality of life (HRQL) is impaired in PSS patients compared to the general population [15,16]. To our knowledge, this is the first qualitative study exploring the individual factors affecting HRQL in PSS. Impaired HRQL may be understood as the overall burden caused by the disease and it’s treatment to patients’ daily individual and social life [17]. The most important dimensions of HRQL include overall physical and social function, burden of symptoms and emotional status and general life satisfaction [18]. A qualitative approach provides the opportunity to assess HRQL in a holistic way including patients’ perspectives and needs [17,19]. The purpose of this study was to explore the perspectives and aspects of HRQL in patients with PSS in a qualitative manner.

Patients and methods

We conducted a qualitative study, guided by a phenomenological approach with focus group interviews to investigate the aspects of HRQoL important to PSS patients. Focus groups were preferred over individual interviews because we expected that the exploration of views and opinions through group discussion would provide more information and concepts than individual questioning [20].

Participants

PSS patients treated at the rheumatology outpatient clinic of the Medical University of Graz were invited by phone to participate in this study. For patient sampling/selection, we followed the “maximum-variation strategy” considering disease duration and age in order to ensure that patients either with new-onset disease as well as with long-standing disease experience were included[21]. Data saturation was determined as the point when sufficient information about the study aim was obtained and no further concepts could be identified. All patients fulfilled the American-European consensus classification criteria [7]. This study was approved by the institutional review board of the Medical University Graz and written informed consent was obtained from all participants.

Focus group interviews

All focus groups were chaired by the same moderator (AL) aided by one assistant (AF) responsible for observing the group, taking field notes and recording the data. The moderator and assistant did not have any pre-existing relationship with the participants, and they were employed as study coordinator and resident physician, respectively at the department of Rheumatology of the Medical University Graz. The moderator was well trained in qualitative research techniques, and she introduced herself at the beginning of the interviews. Interviews were in German language, and they were conducted in a quiet room at the rheumatology outpatient clinic of the Medical University of Graz. For each focus group, a discussion guide was developed with an opening question (patients’ introduction with disease duration, beginning of the disease etc.) and four main open-ended questions based on the three (i.e. the physical, mental and social) dimensions of HRQL (21) and a further literature review (see Table 1 for topic guide).
Table 1

Topic guide used to maintain focus group discussions.

Topic guide
1. Could you introduce yourself and describe the way of your disease?
2. Which PSS-related problems do you experience and which parts of the body are involved? (e.g. Dryness of eyes, mouth, nose, vagina, skin? Side-effects of medication? Limitation through treatment?)
3. Do you experience any difficulties in your activities of daily living? (e.g. which kind of work? Sick leave? Household, hobbies and leisure activities?)
4. Do you experience any limitations in your social environment? (e.g. impairment of social contacts? Support from family/friends?)
At the beginning of each focus group session, the moderator explained the interview process, the aim of the study and started the discussion with interview question 1. Similar to other qualitative studies in rheumatology, the presumed duration of the focus-group discussion was about one hour [22,23]. All interviews were digitally recorded and transcribed verbatim; thereby the patients’ data were anonymised.

Data analysis

A modified meaning condensation procedure was used to analyse the focus group sessions (Fig 1) [24]. All analyses were performed by the moderator (AL). The meaning condensation procedure enables a stepwise reduction of the transcribed text into short formulations reflecting interviewees’ meanings: First, the transcribed focus group interviews were read through to gain an insight into the data material. Second, the data material was divided into ‘meaning units’, which referred to a specific unit of text with a common phrase or a few words or a few sentences with a common meaning. Third, sub-concepts were identified among the meaning units which best reflected the meaning units. A meaning unit could contain more than one sub-concept. Fourth, the identified sub-concepts were grouped into more comprehensive concepts [24]. For the management of interview data and handling of the concepts, we used the software Atlas.Ti (Berlin, Germany) [25]. After analysis three interviewed patients checked and verified the resulted concepts. According to the aim of the study, to explore the aspects of HRQL, the identified concepts were assigned to the most appropriate main dimension of HRQL [18].
Fig 1

Process of data analysis.

Results

Sixty-two patients were invited to this study and 20 (32.3%) finally agreed to participate. The reasons for declining study participation were lack of interest and/or time. Six focus group sessions with three (4 focus groups) or four (2 focus groups) participants each were conducted. Small focus groups of four to six participants were planned [24] but due to non-attendance focus groups were smaller than planned (three to four participants in each). Patients’ characteristics are summarized in Table 2. The average duration of each focus group session was 58 (SD ± 13) minutes.
Table 2

Patient characteristics.

CharacteristicValue
Age, mean ± SD (years)62±8
Disease duration, mean ± SD (years)5±2
Symptom duration before diagnosis, mean ± SD (years)2.7±2.8
Extraglandular symptoms, no. (%)
Arthralgia/Arthritis6 (30)
Raynaud phenomena5 (25)
Lymphadenopathy4 (20)
Depression4 (20)
Fatigue16 (80)
Monoclonal gammopathy of undetermined significance (MGUS)3 (15)
Treatment no. (%)
None11 (55)
Pilocarpine2 (10)
Pilocarpine+Chloroquine3 (15)
Pilocarpine+Hydroxychloroquine1 (5)
Chloroquin1 (5)
Hydroxychloroquine1 (5)
Corticosteroids1 (5)

Concepts and sub-concepts identified in the qualitative analysis

Overall, we retrieved 484 meaning units. These were reduced to 254 sub-concepts and subsequently grouped into 86 concepts (Table 3). The concepts were then assigned to three dimensions: physical, psychological & emotional as well as social life & daily living (Fig 2) [18]. These three dimensions reflect the different aspects of health related quality of life in PSS according to the patients’ perspective.
Table 3

The identified concepts of HRQL in PSS patients.

Concepts
Physical dimensionPsychological & emotional challengesSocial life and daily living
Pain

fear of physician

fear of side effects

feeling of being an encumbrance for relatives

Loneliness

Hobby

Prostration

worries about the future

living with a chronic disease

long way until diagnosis

standard of living

decreased performance

Complaints were dismissed by health professionals

psychological stress (chronic dryness and getting dismissed)

Worsening of complaints when stressed

suicidal ideation

excessive demands

Getting dismissed

impaired self-confidence

dissatisfaction with treatment

lack of understanding for complaints

impossibility to cry

additional stress with family

Impaired social life

Family is considerate of patient

dependency on relatives in daily life

Difficulties at work(computer, speaking, fatigue)

working despite feeling sick

fear of unemployment

different specialists

difficulties at driving a car

Sports

household activities

limitation in nutrition

Eating disturbances

financial dependency

financial stress

hobby

walking

disease education

Dissatisfaction with own appearance

aids for dryness

complaints depend on season

inability to apply make-up

Hospitalization

drug efficacy

physical therapy

complementary medicine

Joints (swelling & stiffness)

back/spine

extremities

stomach

wandering pain

pain due to dryness

Dryness

eyes

mouth

skin

nose

ears

vagina

Additional physical complaints

sensitive to coldness

lymphoma

arthrosis

shortness of breath

loss of muscle power

swelling of lymph nodes

fatigue

Raynaud syndrome

photophobia

Constipation

Depression

Dryness-induced complaints

burning in the mouth

inflammation of eyes &ears

reduced sense of smell

reduced sense of taste

loss of weight

Inability to cry

gritty eye sensation

worsening of vision

speaking

Loss of teeth

sleeping disturbances due to dryness of mouth and eyes

inability to eat and chew

drinking compulsion at night

Side effects

hair loss

excessive sweating

sight disorder

Fig 2

Three main themes of HRQL in PSS patients with their influence among each other.

fear of physician fear of side effects feeling of being an encumbrance for relatives Loneliness Hobby Prostration worries about the future living with a chronic disease long way until diagnosis standard of living decreased performance Complaints were dismissed by health professionals psychological stress (chronic dryness and getting dismissed) Worsening of complaints when stressed suicidal ideation excessive demands Getting dismissed impaired self-confidence dissatisfaction with treatment lack of understanding for complaints impossibility to cry additional stress with family Impaired social life Family is considerate of patient dependency on relatives in daily life Difficulties at work(computer, speaking, fatigue) working despite feeling sick fear of unemployment different specialists difficulties at driving a car Sports household activities limitation in nutrition Eating disturbances financial dependency financial stress hobby walking disease education Dissatisfaction with own appearance aids for dryness complaints depend on season inability to apply make-up Hospitalization drug efficacy physical therapy complementary medicine Joints (swelling & stiffness) back/spine extremities stomach wandering pain pain due to dryness eyes mouth skin nose ears vagina sensitive to coldness lymphoma arthrosis shortness of breath loss of muscle power swelling of lymph nodes fatigue Raynaud syndrome photophobia Constipation Depression burning in the mouth inflammation of eyes &ears reduced sense of smell reduced sense of taste loss of weight Inability to cry gritty eye sensation worsening of vision speaking Loss of teeth sleeping disturbances due to dryness of mouth and eyes inability to eat and chew drinking compulsion at night hair loss excessive sweating sight disorder Most commonly reported concepts were related to the physical dimension (although some concepts could have been assigned to more than one dimension): pain, dryness and complaints secondary to dryness such as painfully dry mucosae, recurrent inflammation of the eyes and ears, sleeping disturbances and the inability to eat and chew. Patients also frequently reported joint pain, shortness of breath, fatigue und constipation. Complaints related to dryness were not limited to the physical dimension. Patients reported for example, that dryness of the oral mucosa resulted in a burning sensation in the mouth, loss of senses of smell and taste, loss of weight, inability to eat and chew food as well as speaking difficulties. These complaints subsequently led to psychological & emotional challenges because of a perceived lack of understanding by relatives as well as difficulties at work, limitation of nutrition and impaired social life. Furthermore, patients’ perceived dryness of eyes caused photophobia, inflammation of the eyes, inability to cry, gritty eye sensation, impaired sight, impossibility to drive a car or work on the computer and financial burden due to expensive eye drops. The three categories and examples for their influence are discussed below, including supporting quotes (G = Group, I = Interviewee).

Physical dimension

The physical dimension revealed the most concepts (n = 38). Among them, five major subcategories were identified: pain, dryness, drug-side effects, dryness-related complications and additional complaints. Patients reported pain of joints, wandering muscle pain and pain due to dryness, as expressed by the following statements: G4, I4: ‘Every week I have pain somewhere else. I mean, the whole spine, feet, the knee. Sometimes I think I’m going crazy. Every week it hurts somewhere else. And I don’t know why.’ G4, I3: ‘Yes, when it doesn’t hurt in the morning, I’m thinking that I’m not alive.’ G4, I2: ‘Every week it hurts somewhere else and you think that can’t be real. The limbs, everything hurts.’ As stated above, dryness caused several secondary complaints. One female patient expressed problems with eating as follows (G4, I4): ‘The whole time I have a bottle of water with me. But, I can’t eat some dry food. You can’t swallow it. You have the feeling that you are suffocating.’ The dryness of mouth also caused sleeping disturbances (G1, I3): ‘Sleeping was just possible, when I was sitting in bed. As soon as I turned around, I had a feeling of suffocation. So I was sleeping in a sitting position for one and a half year.’ The most commonly reported drug side-effect was excessive sweating after intake of pilocarpine, which was the main reason why patients stopped taking this drug. As an example of additional physical complaints, patients experienced sensitiveness to coldness, loss of muscle power, constipation, fatigue and prostration.

Psychological & emotional challenges

Many patients reported about their experiences in the initial phase of the disease, when the diagnosis was not yet established. For most patients, it took several years before they were finally referred to a rheumatologist. They reported that (mainly family) physicians frequently suspected them as having a mental/psychiatric disorder or simply ignored their complaints. One patient described her experience (G3, I1): ‘I had problems with my stomach and digestion, felt pain in my joints. The physician did not find a reason for that. After a while, I also had dry eyes with burning and pain. I went to my general practitioner but he did not take me seriously. Then I recognised that my mouth became dry. I was afraid to go to a doctor because they looked at me, as being crazy myself. They wanted to send me to a psychologist. Then, after 5 years of symptoms and unsatisfying visits at different doctors, one doctor was on the right way and I finally got the diagnosis of Sjögren’s’s. I really felt relieved.’ One patient reported how the inability to cry emotionally challenged her (G2, I4): ‘I’m starting to cry tears, which I don’t have. In former times, when I had problems, I was able to cry and the problems were easier to handle. Now, I want to cry, because I have this disease and pain but I don’t have tears, and the feeling of crying is going by. I just want to cry.’ The feeling of being an encumbrance for family, excessive demand due to complaints and worries about the future were important aspects in this dimension. Most patients recognised that their complaints worsened when they suffered additional stress with family and/or job.

Social life & daily living

PSS patients felt a dependency on relatives in daily life, e.g. most patients were not able to drive a car because of dry eyes or they could not handle the household without help because of pain. Dryness caused difficulties at work particularly in case of a computer work and patients felt that long conversations with customers were challenging. They worked despite feeling sick and were afraid of losing their job. Fatigue was a common reason for impairment of social life as expressed by the following statements: (G2, I2) ‘Yes I can say that I’m often really tired, when friends are calling me; they want to go out after work. But I don’t have enough energy. I don’t want. Then I’m done. Honestly, I’m just happy when I can lay down. I do not have any energy anymore.’ (G5, I2) ‘My husband has adjusted to this situation. But when you are never able to do anything together and you are not fit enough (…) You have to take care. You have to take care because otherwise you will be alone. And the others are living their lives. It is like that. And in the family (…) that hurts.’ (G5, I2) ‘ (…) But now everything is so painful. I can’t go out in the evening. I miss that. I mean, my life is really impaired. Really impaired. And the others can’t understand that. They go riding a bike and you can’t go with them. Yes, then you are alone.’ The most frequently mentioned concepts related to therapy within this dimension included the relevance, efficacy and costs of complementary medicine, conventional drugs, physical therapy and aids for symptoms of dryness. It was particularly emphasized by patients that these therapies caused a significant financial burden.

Discussion

To our knowledge, this project with focus-group interviews is the first qualitative study to explore the experiences and perspectives concerning HRQL in patients with PSS. Pain, dryness and the consequences of dryness (inflammation of eyes and ears, loss of sense of smell and taste etc.) were the concepts most commonly raised by patients [26]. Although these factors belong mainly to the physical dimension, they were also relevant to the psychological/emotional as well as for patients’ social life: Several patients for example were “worried about the future” of their disease, “felt of being an encumbrance for their families” (dimension of social life & daily living). In addition, the symptoms of the disease caused “dependency on relatives in daily life”, “difficulties at work” and “financial burden” (social life & daily living). In daily clinical practice, physicians may currently not pay enough attention to (or even ignore) these aspects of disease because of time constraints and/or lack of awareness. To patients, however, these factors appear to be equally important than physical complaints and should thus be assessed in a systematic manner. Most of the identified concepts belonged to the physical dimension—that was also found in other rheumatic conditions (Psoriatic Arthritis, Systemic Sclerosis, Rheumatoid Arthritis (RA), Systemic Lupus Erythematodes (SLE) and Hand Osteoarthritis) [27]. HRQL of PSS is comparable to that of patients with SLE, RA and Fibromyalgia, as measured by the generic Short Form-36 questionnaire [28,29]. The concept of “inability to cry” was previously reported by another study suggesting that PSS patients, due to the loss of tears, may use other ways of expressing emotions [30]. Another important emotional burden for PSS patients was the long lag from symptom to diagnosis as well as the experience of not being taken seriously by family practitioners and other physicians in the pre-diagnostic phase [31]. Even if a causal (or even effective symptomatic) therapy is not available yet, many patients felt relieved after having been diagnosed with PSS, given that finally they had an explanation for their complaints. Educational programs increasing the awareness of PSS among general practitioners, ophthalmologists, dentists and other specialists might support an early recognition of the disease and thus reduce the emotional stress of patients in the early phase of the disease. The concepts of “a long way until diagnosis” and not “being taken seriously” were also retrieved in qualitative studies of SLE [26] and Systemic Sclerosis [32]. The low level of experience of family physicians with these diseases as well as the wide range of unspecific symptoms might explain this observation. Moreover, there is often a discordance between subjective impairments and objective tests presumably causing misunderstandings and disagreements between physicians and patients concerning the relevance of dryness, fatigue, malaise and other symptoms [33]. Occupational therapy could have a positive impact on coping with PSS symptoms like sleep, pain, fatigue and impairment of daily activities as suggested previously [34]. Another interesting observation is variable perception of the necessity of treatment and medical visits by PSS patients. The majority of patients (at least in the early phase of the disease) desire treatment for symptom relief [35]. The efficacy of current therapies, however, is low to moderate at best [14], and therefore, most patients have developed their own coping strategies to better manage the disease. Some patients questioned the necessity of clinical visits, because “nothing is getting better, so why should we go to the doctor?” On the other hand, many patients were also concerned about the disease course (and complications) and therefore still preferred a regular medical control [36]. The reliable assessment of patients’ outcomes and particularly HRQL in clinical practice as well as treatment studies is an unmet need in PSS. A few patient-derived outcome measures have been developed for the assessment of dryness, fatigue and pain in PSS [8,37]; however, there is no tool for the assessment of PSS related HRQL available yet. Disease specific measures of HRQL have been developed for other rheumatic diseases already such as Rheumatoid Arthritis [38] or Psoriatic Arthritis [39] and the present study might be used as the basis for such an exercise in PSS. An important limitation of our study is that the sample included only patients from one region in Austria, although patients were from different age groups and professional backgrounds. We only included female patients because none of our (few) male patients wanted to participate in this study [5]. A limitation of focus groups is the potential shyness of participants to talk about sensitive topics in front of other, mostly unknown people. Therefore, we cannot exclude that full data enrichment has not been obtained. In summary, pain, dryness and complaints secondary to these symptoms are important to patients with PSS significantly affecting physical, psychological and social life components of HRQL. A tool for the systematic assessments of HRQL in PSS patients is needed for clinical practice and trials, and the results of this study might be used for the development of such a tool.
  31 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  Primary Sjogren's syndrome: too dry and too tired.

Authors:  Wan-Fai Ng; Simon J Bowman
Journal:  Rheumatology (Oxford)       Date:  2010-02-10       Impact factor: 7.580

3.  Dry eyes or mouth--an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome.

Authors:  L T Jacobsson; T E Axell; B U Hansen; V J Henricsson; A Larsson; K Lieberkind; B Lilja; R Manthorpe
Journal:  J Autoimmun       Date:  1989-08       Impact factor: 7.094

Review 4.  Primary Sjögren's syndrome: new clinical and therapeutic concepts.

Authors:  M Ramos-Casals; A G Tzioufas; J Font
Journal:  Ann Rheum Dis       Date:  2004-10-21       Impact factor: 19.103

Review 5.  Treatment of primary Sjögren syndrome: a systematic review.

Authors:  Manuel Ramos-Casals; Athanasios G Tzioufas; John H Stone; Antoni Sisó; Xavier Bosch
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

Review 6.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

Review 7.  Health-related quality-of-life assessment in medical care.

Authors:  A J McSweeny; T L Creer
Journal:  Dis Mon       Date:  1995-01       Impact factor: 3.800

Review 8.  Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis.

Authors:  Yan Liang; Zaixing Yang; Baodong Qin; Renqian Zhong
Journal:  Ann Rheum Dis       Date:  2013-05-17       Impact factor: 19.103

Review 9.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

10.  Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).

Authors:  Raphaèle Seror; Elke Theander; Johan G Brun; Manel Ramos-Casals; Valeria Valim; Thomas Dörner; Hendrika Bootsma; Athanasios Tzioufas; Roser Solans-Laqué; Thomas Mandl; Jacques-Eric Gottenberg; Eric Hachulla; Kathy L Sivils; Wan-Fai Ng; Anne-Laure Fauchais; Stefano Bombardieri; Guido Valesini; Elena Bartoloni; Alain Saraux; Matija Tomsic; Takayuki Sumida; Susumu Nishiyama; Roberto Caporali; Aike A Kruize; Cristina Vollenweider; Philippe Ravaud; Claudio Vitali; Xavier Mariette; Simon J Bowman
Journal:  Ann Rheum Dis       Date:  2014-01-17       Impact factor: 19.103

View more
  17 in total

1.  National Sjögren's Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life.

Authors:  Sara S McCoy; Christie M Bartels; Ian J Saldanha; Vatinee Y Bunya; Esen K Akpek; Matthew A Makara; Alan N Baer
Journal:  J Rheumatol       Date:  2020-09-15       Impact factor: 5.346

2.  Experience of sleep disruption in primary Sjögren's syndrome: A focus group study.

Authors:  Katie L Hackett; Vincent Deary; Katherine Ho Deane; Julia L Newton; Wan-Fai Ng; Tim Rapley
Journal:  Br J Occup Ther       Date:  2018-01-11       Impact factor: 1.243

3.  Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry.

Authors:  Leslie R Harrold; Ying Shan; Sabrina Rebello; Neil Kramer; Sean E Connolly; Evo Alemao; Sheila Kelly; Joel M Kremer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2020-05-24       Impact factor: 2.631

4.  Mixed-Methods Study Identifying Key Intervention Targets to Improve Participation in Daily Living Activities in Primary Sjögren's Syndrome Patients.

Authors:  Katie L Hackett; Katherine H O Deane; Julia L Newton; Vincent Deary; Simon J Bowman; Tim Rapley; Wan-Fai Ng
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-05-21       Impact factor: 4.794

5.  The impact of disease activity and psychological status on quality of life for Chinese patients with primary Sjögren's syndrome.

Authors:  Yafei Cui; Lin Li; Ling Xia; Qian Zhao; Shengnan Chen; Ting Fu; Juan Ji; Zhifeng Gu
Journal:  Patient Prefer Adherence       Date:  2018-08-21       Impact factor: 2.711

6.  Dry eye syndrome and the subsequent risk of chronic fatigue syndrome-a prospective population-based study in Taiwan.

Authors:  Chih-Sheng Chen; Hui-Man Cheng; Hsuan-Ju Chen; Shin-Yi Tsai; Chia-Hung Kao; Hui-Ju Lin; Lei Wan; Tse-Yen Yang
Journal:  Oncotarget       Date:  2018-07-17

7.  The Effectiveness and Safety of Total Glucosides of Paeony in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Zhe Feng; Bi-Qing Zhang; Ya-Mei Zhu; Bei-Bei Yu; Ling Fu; Ling-Ling Zhou; Xue-Ping Zhou; Yan Lu
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810

8.  Personality, depression and anxiety in primary Sjogren's syndrome - Association with sociodemographic factors and comorbidity.

Authors:  Vera Milic; Milica Grujic; Jasmina Barisic; Jelena Marinkovic-Eric; Dragana Duisin; Andja Cirkovic; Nemanja Damjanov
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

9.  How do patients with systemic autoimmune rheumatic disease perceive the use of their medications: a systematic review and thematic synthesis of qualitative research.

Authors:  Hans Haag; Tim Liang; J Antonio Avina-Zubieta; Mary A De Vera
Journal:  BMC Rheumatol       Date:  2018-04-02

10.  Anxiety and depression in primary Sjögren's syndrome: a cross-sectional study.

Authors:  Yafei Cui; Ling Xia; Lin Li; Qian Zhao; Shengnan Chen; Zhifeng Gu
Journal:  BMC Psychiatry       Date:  2018-05-16       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.